PALISADE BIO, INC. (PALI) Total liabilities 2016–2025
PALISADE BIO, INC. (PALI) total liabilities at each fiscal year-end, per SEC filings.
$5.0MFY2025 · since FY2016: $11.3M → $5.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.0M | +46.5% |
| FY2024 | $3.4M | +23.7% |
| FY2023 | $2.7M | -16.6% |
| FY2022 | $3.3M | — |
| FY2020 | $10.1M | +594.0% |
| FY2019 | $1.5M | -10.8% |
| FY2018 | $1.6M | -69.6% |
| FY2017 | $5.4M | -52.4% |
| FY2016 | $11.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More PALI financial trends
PALI RevenuePALI Net incomePALI Net marginPALI Gross profitPALI Gross marginPALI Operating incomePALI Operating marginPALI Operating cash flowPALI Free cash flowPALI Capital expendituresPALI Return on equityPALI Stock buybacksPALI Dividends paidPALI Total assetsPALI Shareholders’ equityPALI overview →